Related Experiment Videos
Prospects for redox-based therapy in neurodegenerative diseases
1Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA.
Neurotoxicity Research
|June 22, 2006
Summary
Redox metabolism disruptions are key in neurodegenerative diseases. New redox-based drugs, acting oxidatively, offer therapeutic potential for these conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Neurodegenerative diseases are increasingly linked to altered redox metabolism.
- Evidence spans genetic, post-mortem, and animal model studies.
- Redox imbalances play a significant role in disease development.
Purpose of the Study:
- To review the evidence linking redox metabolism to neurodegeneration.
- To discuss emerging redox-based therapeutic agents.
Main Methods:
- Review of existing scientific literature.
- Analysis of molecular genetic data.
- Examination of post-mortem human brain studies.
- Biochemical and pathological investigations in animal models.
Main Results:
- Strong evidence supports redox metabolism perturbations in neurodegenerative pathogenesis.
- Redox-based therapeutic agents are emerging.
- These agents exert proximate oxidative effects.
Conclusions:
- Redox metabolism is a critical factor in neurodegenerative disease.
- Oxidative-targeting therapies represent a promising new treatment strategy.
Related Concept Videos
01:24Redox Reactions
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:23Redox Equilibria: Overview
A reduction-oxidation reaction is commonly called a redox reaction. In a redox reaction, electrons are transferred from one species to another rather than being shared between or among atoms. The reducing agent or reductant is the species that loses electrons and gets oxidized in the process. The species that gains electrons and gets reduced in the process is the oxidizing agent or oxidant. Redox reactions are represented as two separate equations called half-reactions, where one equation...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:27Redox Reactions
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...